Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $366.99 Million |
|---|---|
| Enterprise Value | $366.99 Million |
| Earnings per Share | $0 |
| Beta | -2.48 |
| Outstanding Shares | 1,054,689,224 |
| P/E Ratio | -4439.51 |
|---|---|
| PEG | -7068.41 |
| Price to Sales | - |
| Price to Book Ratio | -0.35 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4413.67 |
| Enterprise Value to Net Income | -4414 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious disea...